GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » EV-to-FCF

Jacobson Pharma (HKSE:02633) EV-to-FCF : 7.70 (As of Mar. 31, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jacobson Pharma's Enterprise Value is HK$2,571 Mil. Jacobson Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was HK$334 Mil. Therefore, Jacobson Pharma's EV-to-FCF for today is 7.70.

The historical rank and industry rank for Jacobson Pharma's EV-to-FCF or its related term are showing as below:

HKSE:02633' s EV-to-FCF Range Over the Past 10 Years
Min: 3.81   Med: 7.66   Max: 37.84
Current: 7.7

During the past 11 years, the highest EV-to-FCF of Jacobson Pharma was 37.84. The lowest was 3.81. And the median was 7.66.

HKSE:02633's EV-to-FCF is ranked better than
85.43% of 549 companies
in the Drug Manufacturers industry
Industry Median: 23.45 vs HKSE:02633: 7.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-31), Jacobson Pharma's stock price is HK$1.18. Jacobson Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.129. Therefore, Jacobson Pharma's PE Ratio (TTM) for today is 9.15.


Jacobson Pharma EV-to-FCF Historical Data

The historical data trend for Jacobson Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobson Pharma EV-to-FCF Chart

Jacobson Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.61 8.53 6.67 4.24 4.31

Jacobson Pharma Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.24 - 4.31 -

Competitive Comparison of Jacobson Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobson Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's EV-to-FCF falls into.


;
;

Jacobson Pharma EV-to-FCF Calculation

Jacobson Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2571.175/333.883
=7.70

Jacobson Pharma's current Enterprise Value is HK$2,571 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jacobson Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was HK$334 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobson Pharma  (HKSE:02633) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jacobson Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.18/0.129
=9.15

Jacobson Pharma's share price for today is HK$1.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jacobson Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.129.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Jacobson Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobson Pharma Business Description

Traded in Other Exchanges
N/A
Address
388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG
Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.
Executives
Sum Kwong Yip, Derek 2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Queenshill Development Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines